CLYM (STOCKS)
Climb Bio, Inc. Common Stock
$8.500000
+0.090000 (+1.07%)
Prev close: $8.410000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Aoife M. Brennan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $412.72M
- Employees
- 18
- P/E (TTM)
- -9.49
- P/B (TTM)
- 2.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $67.88M |
| Research and Development | $46.71M |
| Other Operating Expenses | $21.17M |
| Operating Income/Loss | -$67.88M |
| Income/Loss From Continuing Operations After Tax | -$59.85M |
| Income/Loss From Continuing Operations Before Tax | -$59.85M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$59.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$59.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$59.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.88 |
| Diluted Earnings Per Share | -$0.88 |
| Basic Average Shares | 67,812,145 |
| Diluted Average Shares | 67,812,145 |
| Assets | $167.74M |
| Current Assets | $105.85M |
| Cash | $160.70M |
| Noncurrent Assets | $61.90M |
| Fixed Assets | $288.00K |
| Other Non-current Assets | $61.61M |
| Liabilities | $7.27M |
| Current Liabilities | $6.98M |
| Accounts Payable | $2.27M |
| Wages | $1.89M |
| Other Current Liabilities | $2.82M |
| Noncurrent Liabilities | $285.00K |
| Equity | $160.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $160.48M |
| Liabilities And Equity | $167.74M |
| Net Cash Flow From Operating Activities | -$54.36M |
| Net Cash Flow From Operating Activities, Continuing | -$54.36M |
| Net Cash Flow From Investing Activities | $2.83M |
| Net Cash Flow From Investing Activities, Continuing | $2.83M |
| Net Cash Flow From Financing Activities | -$21.00K |
| Net Cash Flow From Financing Activities, Continuing | -$21.00K |
| Net Cash Flow | -$51.54M |
| Net Cash Flow, Continuing | -$51.54M |
| Comprehensive Income/Loss | -$59.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$59.44M |
| Other Comprehensive Income/Loss | $412.00K |